-
Romaco Acquires STE Tecpharm
contractpharma
March 19, 2021
Strengthens Romaco’s processing business with Tecpharm’s drum coaters, coupled with conventional granulation lines and Wurster fluid bed systems.
-
WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China
contractpharma
March 18, 2021
WuXi Biologics has entered into an equity agreement with Pfizer China to acquire its state-of-the-art biologics manufacturing facilities as well as its labor force in Hangzhou, China.
-
Sotera Health Announces Acquisition of Montana-Based BioScience Laboratories
americanpharmaceuticalreview
March 15, 2021
Sotera Health has acquired Montana-based BioScience Laboratories. This acquisition expands the US-based antimicrobial and antiviral testing capabilities of Sotera Health’s Nelson Labs business. Terms of the deal were not disclosed.
-
Takeda exercises option to acquire Maverick Therapeutics for $525m
pharmaceutical-technology
March 11, 2021
Takeda Pharmaceutical Company has exercised its option to acquire Maverick Therapeutics for a pre-negotiated upfront payment and potential development and regulatory milestones totalling up to $525m.
-
Sun Pharma to acquire stake in WRS Bioproducts, Australia
expresspharma
March 08, 2021
WRS Bioproducts develops novel technologies to produce supplements and nutraceutical ingredients from diverse algae species.
-
Alimentiv Acquires McDougall Scientific
contractpharma
March 03, 2021
Niche CRO specializes in statistical analysis, data management, reporting, and clinical trial design.
-
Thermo Fisher Scientific Completes Mesa Biotech Acquisition
contractpharma
March 02, 2021
Thermo Fisher Scientific Inc. has completed its acquisition of Mesa Biotech, Inc., a privately held point-of-care molecular diagnostic company.
-
Arcline Investment Acquires ChargePoint Technology
contractpharma
March 02, 2021
Sterile and contained pharmaceutical product transfer specialist, ChargePoint Technology has been acquired by Arcline Investment Management.
-
Grace to expand pharma portfolio with Albemarle’s business acquisition
pharmaceutical-technology
March 01, 2021
US-based company W R Grace is set to expand its pharma portfolio with the acquisition of Albemarle’ Fine Chemistry Services business (FCS) for about $570m.
-
Wavelength Pharmaceuticals Acquires Majority Stake in Vanamali Organics
contractpharma
February 20, 2021
Wavelength Pharmaceuticals, a developer and manufacturer of active pharmaceutical ingredients (APIs), has acquired a majority stake in Vanamali Organics Pvt. Ltd. of Telangana, India.